Literature DB >> 2197376

Cognitive function in hypertensives treated with atenolol or propranolol.

D M Palac1, R D Cornish, W J McDonald, D A Middaugh, D Howieson, S P Bagby.   

Abstract

STUDY
OBJECTIVE: To test reports that beta blockers, particularly lipophilic forms, impair cognitive function and cause psychiatric disturbances.
DESIGN: Randomized, double-blind, controlled crossover trial with eight-week treatment periods. PATIENTS: Sequential sample of 42 male veterans, with untreated diastolic blood pressures (DBP) between 90 and 110 mmHg, aged 35-64 years.
INTERVENTIONS: Propranolol-LA, 80-mg tablets, or atenolol, 50-mg tablets, were given daily, incremented by one tablet at weekly intervals until DBP less than or equal to 90 mmHg. Hydrochlorothiazide was added, if necessary. MAIN
RESULTS: Repeated-measures ANOVA was performed on all cognitive tests. Cognitive test performance was not affected by beta blocker therapy in seven of nine tests and was enhanced on Trail Making Test. Performance was impaired only on Digit Cancellation. Neither Speilberger's State Trait Anxiety Inventory nor the Beck Depression Inventory was affected by either beta blocker.
CONCLUSIONS: Atenolol or propranolol therapy does not impair cognitive function or contribute significantly to psychiatric side effects.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2197376     DOI: 10.1007/bf02600398

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  35 in total

1.  Electrocardiogram, plasma catecholamines and lipids, and their modification by oxyprenolol when speaking before an audience.

Authors:  P Taggart; M Carruthers; W Somerville
Journal:  Lancet       Date:  1973-08-18       Impact factor: 79.321

2.  Intelligence and blood pressure in the aged.

Authors:  F Wilkie; C Eisdorfer
Journal:  Science       Date:  1971-05-28       Impact factor: 47.728

3.  The effect of propranolol on human psychomotor performance.

Authors:  A D Broadhurst
Journal:  Aviat Space Environ Med       Date:  1980-02

4.  Propranolol, psychoneuroendocrine changes, and depression.

Authors:  B Kalayam; C A Shamoian
Journal:  Am J Psychiatry       Date:  1982-10       Impact factor: 18.112

5.  Neuropsychological correlates of hypertension.

Authors:  F Boller; P B Vrtunski; J L Mack; Y Kim
Journal:  Arch Neurol       Date:  1977-11

6.  Differential effects of atenolol and enalapril on memory during treatment for essential hypertension.

Authors:  I Lichter; P J Richardson; M A Wyke
Journal:  Br J Clin Pharmacol       Date:  1986-06       Impact factor: 4.335

7.  Impairment of memory function by antihypertensive medication.

Authors:  S Solomon; E Hotchkiss; S M Saravay; C Bayer; P Ramsey; R S Blum
Journal:  Arch Gen Psychiatry       Date:  1983-10

8.  A longitudinal comparison of hypertensives and normotensives on the Wechsler Adult Intelligence Scale: initial findings.

Authors:  N R Schultz; M F Elias; M A Robbins; D H Streeten; N Blakeman
Journal:  J Gerontol       Date:  1986-03

9.  Neuropsychological deficits in arterial hypertension.

Authors:  A Mazzucchi; A Mutti; A Poletti; C Ravanetti; A Novarini; M Parma
Journal:  Acta Neurol Scand       Date:  1986-06       Impact factor: 3.209

10.  Central and peripheral effects of propranolol and sotalol in normal human subjects.

Authors:  M H Lader; P J Tyrer
Journal:  Br J Pharmacol       Date:  1972-07       Impact factor: 8.739

View more
  6 in total

Review 1.  Management of mild hypertension. Selecting an antihypertensive regimen.

Authors:  E J Pérez-Stable
Journal:  West J Med       Date:  1991-01

Review 2.  Psychomotor performance and antihypertensive treatment.

Authors:  L Kalra; C G Swift; S H Jackson
Journal:  Br J Clin Pharmacol       Date:  1994-02       Impact factor: 4.335

3.  The Association of Beta-Blocker Use to Cognitive Impairment among Adults with Hypertension or Cardiovascular Diseases in the United States.

Authors:  Fnu Safarudin; Chibuzo O Iloabuchi; Amit Ladani; Usha Sambamoorthi
Journal:  Chronic Pain Manag       Date:  2020-06-01

Review 4.  Effect of antihypertensive agents on quality of life in the elderly.

Authors:  Roberto Fogari; Annalisa Zoppi
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

5.  Assessment of cognitive function in patients with essential hypertension treated with lercanidipine.

Authors:  J Tisaire-Sánchez; J Roma; Ignacio Camacho-Azcargorta; J Bueno-Gómez; J Mora-Maciá; Angel Navarro
Journal:  Vasc Health Risk Manag       Date:  2006

Review 6.  Migraine Pharmacological Treatment and Cognitive Impairment: Risks and Benefits.

Authors:  Mirella Russo; Matteo A De Rosa; Dario Calisi; Stefano Consoli; Giacomo Evangelista; Fedele Dono; Matteo Santilli; Alberto Granzotto; Marco Onofrj; Stefano L Sensi
Journal:  Int J Mol Sci       Date:  2022-09-27       Impact factor: 6.208

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.